B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Dnl 201

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dnl 201, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

mli
2 shared targets
pictilisib
2 shared targets · score 46.2
erlotinib
2 shared targets
rebastinib
2 shared targets
Axitinib
2 shared targets · score 51.2
ruxolitinib
2 shared targets
midostaurin
2 shared targets
ast
2 shared targets
nintedanib
2 shared targets
su
2 shared targets
Loading evidence profile...

This evidence profile for Dnl 201 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.